Clinical Research

Mayo Clinic develops AI capable of substantially improving dementia diagnoses
With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.
AI helps spot fatty liver disease on routine radiographs
If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.
How anti-DEI healthcare policies are impacting patient care
All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.
First 250 patients enrolled in transcatheter heart failure device trial to reduce LV size
The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.
Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs
POCUS could represent a quick, easy and affordable way to detect signs of insulin resistance before it progresses into diabetes, researchers suggest.

Mayo Clinic develops AI capable of substantially improving dementia diagnoses

With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.

AI helps spot fatty liver disease on routine radiographs

If left undiagnosed and untreated for a prolonged period, fatty liver disease can progress to more serious conditions, such as cirrhosis and liver cancer.

The first Black American College of Cardiology (ACC) president Kim Allan Williams, Sr., MD, MACC, MASNC, FAHA, FESC, chair, department of medicine, University of Louisville School of Medicine, explains the impact of Trump administration restrictions on diversity equity and inclusion (DEI) on healthcare programs and clinical trials that address women, minority and low-income patients.

How anti-DEI healthcare policies are impacting patient care

All over the United States, countless research projects designed to improve outcomes have lost funding or been shut down. Even screening efforts targeting patients in impoverished communities have been impacted by these policies.

Ancora Heart AccuCinch Ventricular Restoration System heart failure FDA

First 250 patients enrolled in transcatheter heart failure device trial to reduce LV size

The first 250 patients has been enrolled in the CORCINCH-HF U.S. pivotal trial evaluating the AccuCinch Transcatheter Left Ventricular Restoration System in patients with HFrEF.

Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs

POCUS could represent a quick, easy and affordable way to detect signs of insulin resistance before it progresses into diabetes, researchers suggest.

Statue of Liberty New York City healthcare

Late-breaking clinical trials announced for New York Valves 2025

The three-day event is now in its second year. Each day will feature late-breaking clinical trials focused on a different heart valve.

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.

Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.